Access to anti-retroviral drugs, male in Kyrgyzstan
Kyrgyzstan: Access to anti-retroviral drugs, male was 48.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in Kyrgyzstan, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
Kyrgyzstan recorded 48.0% for access to anti-retroviral drugs, male in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 4.3% on the previous year and up 166.7% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Kyrgyzstan peaked at 48.0% in 2024 and was at its lowest, 0.0%, in 2000.
Kyrgyzstan ranks 120th of 141 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in Kyrgyzstan, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 4.0% | — |
| 2006 | 4.0% | +0.0% |
| 2007 | 3.0% | -25.0% |
| 2008 | 3.0% | +0.0% |
| 2009 | 4.0% | +33.3% |
| 2010 | 5.0% | +25.0% |
| 2011 | 6.0% | +20.0% |
| 2012 | 7.0% | +16.7% |
| 2013 | 12.0% | +71.4% |
| 2014 | 18.0% | +50.0% |
| 2015 | 21.0% | +16.7% |
| 2016 | 25.0% | +19.0% |
| 2017 | 29.0% | +16.0% |
| 2018 | 32.0% | +10.3% |
| 2019 | 33.0% | +3.1% |
| 2020 | 36.0% | +9.1% |
| 2021 | 40.0% | +11.1% |
| 2022 | 44.0% | +10.0% |
| 2023 | 46.0% | +4.5% |
| 2024 | 48.0% | +4.3% |
Kyrgyzstan compared with similar countries
- Kyrgyzstan's 48.0% is below the median for lower middle income countries, which is 71.0%, 68% of the median. (39 countries reporting)
- Kyrgyzstan's 48.0% is below the median for Europe & Central Asia, which is 82.0%, 59% of the median. (33 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 1.8% | 0.0% | 4.0% | 10 |
| 2010s | 18.8% | 5.0% | 33.0% | 10 |
| 2020s | 42.8% | 36.0% | 48.0% | 5 |
Countries ranked near Kyrgyzstan
More gender data for Kyrgyzstan
- Child population (UN estimates and projections) 2,300 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.5338 % change on previous year (2030)
- Population 5,504 (2030)
- Working-age population (UN estimates and projections) 5,504 (2030)
- Population (UN estimates and projections), annual growth rate 2.06 % change on previous year (2030)
- Age population, age 00, female, interpolated 72,260 (2025)
- Age population, age 00, male, interpolated 76,154 (2025)
- Age population, age 01, female, interpolated 72,405 (2025)
- Age population, age 01, male, interpolated 76,252 (2025)
- Age population, age 02, female, interpolated 72,315 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Kyrgyzstan?
- Access to anti-retroviral drugs, male in Kyrgyzstan was 48.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Kyrgyzstan?
- The highest recorded value was 48.0% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in Kyrgyzstan?
- The lowest recorded value was 0.0% in 2000.
- How does Kyrgyzstan rank for access to anti-retroviral drugs, male?
- Kyrgyzstan ranks 120th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Kyrgyzstan?
- Over the last ten years it is up 166.7%. The long-run trend across the full record is volatile.
- Where does this Kyrgyzstan data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.